Prevention of Relapse of Healed Reflux Esophagitis is Related to the Duration of Intragastric pH>4
David A. Johnson(University of Chicago), Péter Nagy(AstraZeneca (Sweden)), Doug Levine(AstraZeneca (United Kingdom)), Magnus Åstrand(AstraZeneca (Sweden)), Philip O. Katz(Cornell University), Ola Junghard(AstraZeneca (Sweden)), Kerstin Röhss(AstraZeneca (Sweden))
Cited by 14
Related Papers
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
|Circulation|2008|845
Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: Effect of omeprazole
|Gastroenterology|2001|614
Nocturnal Recovery of Gastric Acid Secretion With Twice-Daily Dosing of Proton Pump Inhibitors
|The American Journal of Gastroenterology|1998|319